Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$37.30 USD
+0.28 (0.76%)
Updated May 7, 2024 04:00 PM ET
After-Market: $37.32 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: AMC |
3/2024 | $1.49 | -0.67% |
Earnings Summary
For their last quarter, Collegium Pharmaceutical (COLL) reported earnings of $1.58 per share, beating the Zacks Consensus Estimate of $1.33 per share. This reflects a positive earnings surprise of 18.80%. Look out for COLL's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of $1.49 per share, reflecting a year-over-year increase of 12.88%.
Earnings History
Price & Consensus
Zacks News for COLL
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services